A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.
Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy
Pregnant female patients younger than 18 years of age
Confirmed multiple gestation
University of California, San Francisco
Lead sponsor
Crohn's and Colitis Foundation
Collaborator